29.65
1.33%
-0.4448
BridgeBio Pharma Inc (BBIO) 재무 분석
손익 계산서
분기별
*모든 숫자는 백만 단위입니다.
기간 종료일 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 |
기간 | 3개월 | 3개월 | 3개월 | 3개월 | 3개월 |
Revenues |
57.35%
1.745
|
4.091 | 1.641 | 1.826 | 1.87 |
Cost Of Revenue |
0.00%
0.598
|
0.598 | 0.599 | 0.651 | - |
Gross Profit |
67.16%
1.147
|
3.493 | 1.042 | 1.175 | - |
Operating Expenses
|
10.78%
178.56
|
161.19 | 147.14 | 127.99 | 131.10 |
Interest Income/Expense |
0.19%
20.27
|
20.31 | 20.59 | 20.12 | 19.99 |
Benefits Costs and Expenses |
6.27%
172.07
|
183.58 | 162.34 | 144.56 | 142.44 |
Costs And Expenses |
10.74%
179.16
|
161.78 | 147.74 | 127.99 | 131.10 |
Operating Income/Loss |
12.51%
-177.42
|
-157.69 | -146.10 | -126.16 | -129.23 |
Nonoperating Income/Loss |
132.52%
7.088
|
-21.80 | -14.60 | -16.57 | -11.34 |
Income/Loss From Continuing Operations Before Tax |
5.10%
-170.33
|
-179.49 | -160.70 | -142.73 | -140.57 |
Income/Loss From Continuing Operations After Tax |
5.10%
-170.33
|
-179.49 | -160.70 | -142.73 | -140.57 |
Net Income/Loss
|
5.10%
-170.33
|
-179.49 | -160.70 | -142.73 | -140.57 |
Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
Attributable To Noncontrolling Interest |
12.41%
-2.18
|
-2.489 | -2.804 | -2.576 | -2.979 |
Basic Average Shares |
97.61%
3.9004
|
163.31 | 160.54 | 152.65 | 0.6306 |
Diluted Average Shares |
97.61%
3.9004
|
163.31 | 160.54 | 152.65 | 0.6306 |
Basic Earnings Per Share |
11.11%
-0.96
|
-1.08 | -0.98 | -0.92 | -0.92 |
Diluted Earnings Per Share |
11.11%
-0.96
|
-1.08 | -0.98 | -0.92 | -0.92 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
자본화:
|
볼륨(24시간):